| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AX03) | methotrexate; systemic | 25144 | |
| PURCH | PURCH_ATC(L04AX01) | azathioprine; systemic | 9391 | |
| PURCH | PURCH_ATC(L04AB04) | adalimumab; parenteral | 5144 | |
| PURCH | PURCH_ATC(L04AA13) | [U] leflunomide | 4932 | |
| PURCH | PURCH_ATC(L04AA06) | mycophenolic acid; systemic | 3995 | |
| PURCH | PURCH_ATC(L04AD01) | ciclosporin; systemic | 3639 | |
| PURCH | PURCH_ATC(L04AB01) | etanercept; parenteral | 3322 | |
| PURCH | PURCH_ATC(L04AA01) | [U] ciclosporin | 2471 | |
| PURCH | PURCH_ATC(L04AD02) | tacrolimus; systemic | 2016 | |
| PURCH | PURCH_ATC(L04AB06) | golimumab; parenteral | 1661 | |
| PURCH | PURCH_ATC(L04AK01) | leflunomide; oral | 1164 | |
| PURCH | PURCH_ATC(L04AC05) | ustekinumab; parenteral | 984 | |
| PURCH | PURCH_ATC(L04AB02) | infliximab; parenteral | 980 | |
| PURCH | PURCH_ATC(L04AB05) | certolizumab pegol; parenteral | 898 | |
| PURCH | PURCH_ATC(L04AC10) | secukinumab; parenteral | 836 | |
| PURCH | PURCH_ATC(L04AA24) | abatacept; parenteral | 785 | |
| PURCH | PURCH_ATC(L04AX04) | lenalidomide; oral | 736 | |
| PURCH | PURCH_ATC(L04AC07) | tocilizumab; parenteral | 598 | |
| PURCH | PURCH_ATC(L04AX07) | dimethyl fumarate; oral | 598 | |
| PURCH | PURCH_ATC(L04AA11) | [U] etanercept | 594 | |
| PURCH | PURCH_ATC(L04AC13) | ixekizumab; parenteral | 574 | |
| PURCH | PURCH_ATC(L04AA29) | [U] tofacitinib | 512 | |
| PURCH | PURCH_ATC(L04AA17) | [U] adalimumab | 504 | |
| PURCH | PURCH_ATC(L04AA32) | apremilast; oral | 491 | |
| PURCH | PURCH_ATC(L04AG05) | vedolizumab; parenteral | 461 | |
| PURCH | PURCH_ATC(L04AF03) | upadacitinib; oral | 454 | |
| PURCH | PURCH_ATC(L04AA31) | [U] teriflunomide | 438 | |
| PURCH | PURCH_ATC(L04AC18) | risankizumab; parenteral | 425 | |
| PURCH | PURCH_ATC(L04AX05) | pirfenidone; oral | 383 | |
| PURCH | PURCH_ATC(L04AA27) | [U] fingolimod | 362 | |
| PURCH | PURCH_ATC(L04AC16) | guselkumab; systemic | 354 | |
| PURCH | PURCH_ATC(L04AA33) | [U] vedolizumab | 341 | |
| PURCH | PURCH_ATC(L04AA37) | [U] baricitinib | 314 | |
| PURCH | PURCH_ATC(L04AA44) | [U] upadacitinib | 280 | |
| PURCH | PURCH_ATC(L04AC14) | sarilumab; systemic | 280 | |
| PURCH | PURCH_ATC(L04AG12) | ofatumumab; parenteral | 212 | |
| PURCH | PURCH_ATC(L04AX06) | pomalidomide; oral | 207 | |
| PURCH | PURCH_ATC(L04AC21) | bimekizumab; systemic | 195 | |
| PURCH | PURCH_ATC(L04AK02) | teriflunomide; oral | 190 | |
| PURCH | PURCH_ATC(L04AF01) | tofacitinib; oral | 188 | |
| PURCH | PURCH_ATC(L04AA05) | [U] tacrolimus | 164 | |
| PURCH | PURCH_ATC(L04AE01) | fingolimod; oral | 138 | |
| PURCH | PURCH_ATC(L04AA40) | cladribine; oral | 131 | |
| PURCH | PURCH_ATC(L04AF02) | baricitinib; oral | 131 | |
| PURCH | PURCH_ATC(L04AA52) | [U] ofatumumab; parenteral | 114 | |
| PURCH | PURCH_ATC(L04AA10) | [U] sirolimus | 111 | |
| PURCH | PURCH_ATC(L04AX02) | thalidomide; oral | 93 | |
| PURCH | PURCH_ATC(L04AC03) | anakinra; parenteral | 55 | |
| PURCH | PURCH_ATC(L04AX09) | diroximel fumarate; oral | 51 | |
| PURCH | PURCH_ATC(L04AH01) | sirolimus; oral | 48 | |
| PURCH | PURCH_ATC(L04AA45) | [U] filgotinib | 36 | |
| PURCH | PURCH_ATC(L04AH02) | everolimus; oral | 36 | |
| PURCH | PURCH_ATC(L04AA14) | [U] anakinra | 35 | |
| PURCH | PURCH_ATC(L04AA18) | [U] everolimus | 29 | |
| PURCH | PURCH_ATC(L04AF04) | filgotinib; oral | 29 | |
| PURCH | PURCH_ATC(L04AF07) | deucravacitinib; oral | 28 | |
| PURCH | PURCH_ATC(L04AA21) | [U] efalizumab | 17 | |
| PURCH | PURCH_ATC(L04AC12) | brodalumab; systemic | 11 | |
| PURCH | PURCH_ATC(L04AC17) | tildrakizumab; parenteral | 8 |